Incremental prognostic value of left atrial and biventricular feature tracking in dilated cardiomyopathy: a long-term study

Table 3 Multivariable Cox analysis for prediction of MACE in DCM

Variables	LAεe model		LVGLS model		RVGLS model		LAΕE + LVGLS model		LAεe + LVGLS + RVGLS model
Variables	HR(95% CI)	P Value	HR(95% CI)	P Value	HR(95% CI)	P Value	HR(95% CI)	P Value	HR(95% CI)	P value
Age	0.99 (0.97–1.00)	0.015	0.99 (0.98–1.00)	0.061	1.00 (0.98–1.01)	0.353	0.99 (0.97–1.00)	0.015	0.99 (0.97–1.00)	0.016
NYHA class III-IV	1.03 (0.72–1.46)	0.869	1.00 (0.69–1.43)	0.984	1.08 (0.76–1.55)	0.668	1.04 (0.73–1.48)	0.839	1.04 (0.73–1.48)	0.839
NT-proBNP	1.25 (1.15–1.36)	< 0.001	1.35 (1.25–1.47)	< 0.001	1.32 (1.22–1.44)	< 0.001	1.25 (1.15–1.36)	< 0.001	1.25 (1.15–1.36)	< 0.001
LVEF	0.98 (0.96–1.01)	0.118	0.99 (0.96–1.02)	0.397	0.98 (0.96–1.00)	0.101	0.98 (0.96–1.01)	0.119	0.98 (0.96–1.01)	0.121
LGE presence	2.80 (1.84–4.27)	< 0.001	3.37 (2.21–5.13)	< 0.001	3.10 (2.04–4.73)	< 0.001	2.79 (1.83–4.25)	< 0.001	2.79 (1.83–4.27)	< 0.001
LAεe	0.75 (0.70–0.80)	< 0.001	n/a	n/a	n/a	n/a	0.74 (0.68–0.80)	< 0.001	0.74 (0.68–0.81)	< 0.001
LVGLS	n/a	n/a	1.12 (1.06–1.17)	< 0.001	n/a	n/a	0.99 (0.93–1.04)	0.723	0.99 (0.94–1.05)	0.743
RVGLS	n/a	n/a	n/a	n/a	1.06 (1.03–1.09)	< 0.001	n/a	n/a	0.10 (0.97–1.03)	0.979

HR: Hazard Ratio; CI: confidence intervals; n/a: Not applicable, other abbreviations as in Table 1

ISSN: 1532-429X